E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers T > Headlines for Tenders 2005 > News item
Published on 12/5/2005 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.

Invitrogen buys back $100 million 2.25% convertibles

New York, Dec. 5 - Invitrogen Corp. said it repurchased $100 million of its 2.25% convertible subordinated notes due 2006 last week.

Invitrogen is a Carlsbad, Calif., maker of products and services for life sciences research.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.